Kite Pharma Inc. buy melinda
Start price
31.08.17
/
50%
€160.57
Target price
05.10.17
€166.87
Performance (%)
0.99%
End price
05.10.17
€162.17
Summary
This prediction ended on 05.10.17 with a price of €162.17. During the runtime of the prediction for Kite Pharma Inc. the price only changed by 0.99%. melinda has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Kite Pharma Inc. | - | - | - | - |
iShares Core DAX® | -1.114% | 3.430% | 25.966% | 25.039% |
iShares Nasdaq 100 | 1.816% | 6.911% | 30.390% | 48.139% |
iShares Nikkei 225® | 2.113% | 5.501% | 23.404% | 11.979% |
iShares S&P 500 | 2.038% | 5.327% | 30.881% | 46.982% |
Comments by melinda for this prediction
In the thread Kite Pharma Inc. diskutieren
pharma
Kite Pharma, Inc.KITECéloleucel von Axicabtagène (KTE-C19) (BLA) bei der FDA Entscheidung über die KTE-C19 für Non-Hodgkin-Lymphom 2017.11.29
(Vom Mitglied beendet)